Terms: = Ovarian cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C
61 results:
1. The preoperative platelet to neutrophil ratio and lymphocyte to monocyte ratio are superior prognostic indicators compared with other inflammatory biomarkers in ovarian cancer.
Song Q; Xu SX; Wu JZ; Ling L; Wang S; Shu XH; Ying DN; Pei WW; Wu YC; Sun SF; Zhang YN; Zhou SH; Shao ZY
Front Immunol; 2023; 14():1177403. PubMed ID: 37457691
[TBL] [Abstract] [Full Text] [Related]
2. Diabetes risk reduction diet and ovarian cancer risk: an Italian case-control study.
Esposito G; Turati F; Parazzini F; Augustin LSA; Serraino D; Negri E; La Vecchia C
Cancer Causes Control; 2023 Sep; 34(9):769-776. PubMed ID: 37221355
[TBL] [Abstract] [Full Text] [Related]
3. cancer Risk Associated With
Cummings S; Alfonso A; Hughes E; Kucera M; Mabey B; Singh N; Eng C
JCO Precis Oncol; 2023 Jan; 7():e2200415. PubMed ID: 36634299
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis.
Travaglino A; Raffone A; Raimondo D; Reppuccia S; Ruggiero A; Arena A; Casadio P; Zullo F; Insabato L; Seracchioli R; Mollo A
Arch Gynecol Obstet; 2022 Aug; 306(2):423-431. PubMed ID: 35034160
[TBL] [Abstract] [Full Text] [Related]
5. Clinical significance for combined coagulation indexes in epithelial ovarian cancer prognosis.
Yang J; Jin Y; Cheng S; Wang C; Zhang N; Huang S; Zhao Y; Wang Y
J Ovarian Res; 2021 Aug; 14(1):106. PubMed ID: 34404438
[TBL] [Abstract] [Full Text] [Related]
6. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.
Baxter JS; Johnson N; Tomczyk K; Gillespie A; Maguire S; Brough R; Fachal L; Michailidou K; Bolla MK; Wang Q; Dennis J; Ahearn TU; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Augustinsson A; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bogdanova NV; Bojesen SE; Brenner H; Brucker SY; Cai Q; Campa D; Canzian F; Castelao JE; Chan TL; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Choi JY; Clarke CL; ; Colonna S; Conroy DM; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dossus L; Dwek M; Eccles DM; Ekici AB; Eliassen AH; Engel C; Fasching PA; Figueroa J; Flyger H; Gago-Dominguez M; Gao C; García-Closas M; García-Sáenz JA; Ghoussaini M; Giles GG; Goldberg MS; González-Neira A; Guénel P; Gündert M; Haeberle L; Hahnen E; Haiman CA; Hall P; Hamann U; Hartman M; Hatse S; Hauke J; Hollestelle A; Hoppe R; Hopper JL; Hou MF; ; ; Ito H; Iwasaki M; Jager A; Jakubowska A; Janni W; John EM; Joseph V; Jung A; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kosma VM; Kraft P; Kristensen VN; Kubelka-Sabit K; Kurian AW; Kwong A; Lacey JV; Lambrechts D; Larson NL; Larsson SC; Le Marchand L; Lejbkowicz F; Li J; Long J; Lophatananon A; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Matsuo K; Mavroudis D; Mayes R; Menon U; Milne RL; Mohd Taib NA; Muir K; Muranen TA; Murphy RA; Nevanlinna H; O'Brien KM; Offit K; Olson JE; Olsson H; Park SK; Park-Simon TW; Patel AV; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Pylkäs K; Rack B; Rennert G; Romero A; Ruebner M; Rüdiger T; Saloustros E; Sandler DP; Sawyer EJ; Schmidt MK; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Shah M; Shen CY; Shu XO; Simard J; Southey MC; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Taylor JA; Teo SH; Teras LR; Terry MB; Toland AE; Tomlinson I; Truong T; Tseng CC; Untch M; Vachon CM; van den Ouweland AMW; Wang SS; Weinberg CR; Wendt C; Winham SJ; Winqvist R; Wolk A; Wu AH; Yamaji T; Zheng W; Ziogas A; Pharoah PDP; Dunning AM; Easton DF; Pettitt SJ; Lord CJ; Haider S; Orr N; Fletcher O
Am J Hum Genet; 2021 Jul; 108(7):1190-1203. PubMed ID: 34146516
[TBL] [Abstract] [Full Text] [Related]
7. A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent ovarian cancer.
Kazmi F; Nicum S; Roux RL; Spiers L; Gnanaranjan C; Sukumaran A; Gabra H; Ghazaly E; McCracken NW; Harrison DJ; Blagden SP
Clin Cancer Res; 2021 Jun; 27(11):3028-3038. PubMed ID: 33741651
[TBL] [Abstract] [Full Text] [Related]
8. Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in ovarian Tumour Models.
Althurwi SI; Yu JQ; Beale P; Huq F
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053689
[TBL] [Abstract] [Full Text] [Related]
9. NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trials.
Kapacee ZA; Knox JJ; Palmer D; Blagden SP; Lamarca A; Valle JW; McNamara MG
Med Oncol; 2020 Jun; 37(7):61. PubMed ID: 32529264
[TBL] [Abstract] [Full Text] [Related]
10. Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib.
Wang Z; Gao J; Ohno Y; Liu H; Xu C
Cancer Chemother Pharmacol; 2020 Feb; 85(2):273-284. PubMed ID: 31907647
[TBL] [Abstract] [Full Text] [Related]
11. Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031.
Sarr A; Bré J; Um IH; Chan TH; Mullen P; Harrison DJ; Reynolds PA
Sci Rep; 2019 May; 9(1):7643. PubMed ID: 31113993
[TBL] [Abstract] [Full Text] [Related]
12. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract] [Full Text] [Related]
13. Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels.
Lee K; Seifert BA; Shimelis H; Ghosh R; Crowley SB; Carter NJ; Doonanco K; Foreman AK; Ritter DI; Jimenez S; Trapp M; Offit K; Plon SE; Couch FJ
Genet Med; 2019 Jul; 21(7):1497-1506. PubMed ID: 30504931
[TBL] [Abstract] [Full Text] [Related]
14. Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study.
Merritt MA; Rice MS; Barnard ME; Hankinson SE; Matulonis UA; Poole EM; Tworoger SS
Lancet Oncol; 2018 Aug; 19(8):1107-1116. PubMed ID: 30029888
[TBL] [Abstract] [Full Text] [Related]
15. Impact of a decision aid about stratified ovarian cancer risk-management on women's knowledge and intentions: a randomised online experimental survey study.
Meisel SF; Freeman M; Waller J; Fraser L; Gessler S; Jacobs I; Kalsi J; Manchanda R; Rahman B; Side L; Wardle J; Lanceley A; Sanderson SC;
BMC Public Health; 2017 Nov; 17(1):882. PubMed ID: 29145813
[TBL] [Abstract] [Full Text] [Related]
16. ovarian cancer: Prevalence in Incidental Simple Adnexal Cysts Initially Identified in CT Examinations of the Abdomen and Pelvis.
Boos J; Brook OR; Fang J; Brook A; Levine D
Radiology; 2018 Jan; 286(1):196-204. PubMed ID: 28914598
[TBL] [Abstract] [Full Text] [Related]
17. Somatic mutations in cancer: Stochastic versus predictable.
Gold B
Mutat Res Genet Toxicol Environ Mutagen; 2017 Feb; 814():37-46. PubMed ID: 28137366
[TBL] [Abstract] [Full Text] [Related]
18. Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer.
Fruscio R; Ceppi L; Corso S; Galli F; Dell'Anna T; Dell'Orto F; Giuliani D; Garbi A; Chiari S; Mangioni C; Milani R; Floriani I; Colombo N; Bonazzi CM
Br J Cancer; 2016 Sep; 115(6):641-8. PubMed ID: 27537385
[TBL] [Abstract] [Full Text] [Related]
19. Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank ovarian cancer (TOC).
Rohr I; Braicu EI; En-Nia A; Heinrich M; Richter R; Chekerov R; Dechend R; Heidecke H; Dragun D; Schäfer R; Gorny X; Lindquist JA; Brandt S; Sehouli J; Mertens PR
Cytokine; 2016 Sep; 85():157-64. PubMed ID: 27371774
[TBL] [Abstract] [Full Text] [Related]
20. The incidence of endometrial hyperplasia and cancer in 1031 patients with a granulosa cell tumor of the ovary: long-term follow-up in a population-based cohort study.
van Meurs HS; Bleeker MC; van der Velden J; Overbeek LI; Kenter GG; Buist MR
Int J Gynecol Cancer; 2013 Oct; 23(8):1417-22. PubMed ID: 24257556
[TBL] [Abstract] [Full Text] [Related]
[Next]
